https://news.medxy.ai/zh/placenta-penetration-removal/Medxy AIzh2026-10-07T06:03:08-07:00基于病理解剖学的胎盘穿透性植入局灶切除：应对新生血管化难题的保宫策略 https://news.medxy.ai/ja/81583-2/Medxy AIja2026-10-07T06:02:49-07:00病理解剖学的知見に基づく胎盤穿通性癒着胎盤の局所切除：新生血管形成という難題に対処する子宮温存戦略 https://news.medxy.ai/vi/81582-2/Medxy AIvi2026-10-07T06:02:28-07:00Cắt bỏ khu trú nhau cài răng lược xuyên cơ dựa trên giải phẫu bệnh: Chiến lược bảo tồn tử cung nhằm giải quyết thách thức về sự tân tạo mạch máu https://news.medxy.ai/zh/hifu-twin-twin-transfusion/Medxy AIzh2026-10-07T06:01:27-07:00超声引导高强度聚焦超声：早发型双胎输血综合征胎盘血管闭塞的新选择 https://news.medxy.ai/ja/early-twin-transfusion-treatment/Medxy AIja2026-10-07T06:01:09-07:00早発性双胎間輸血症候群に対する超音波ガイド下高強度集束超音波――胎盤血管を安全に閉塞しうる新規治療の検討 https://news.medxy.ai/vi/hifu-placental-blood-flow/Medxy AIvi2026-10-07T06:00:48-07:00Khám phá HIFU có hướng dẫn bằng siêu âm trong bít tắc an toàn các mạch máu nhau thai ở hội chứng truyền máu song thai khởi phát sớm https://news.medxy.ai/zh/81153-2/Medxy AIzh2026-10-06T07:08:11-07:00影响NAION视功能恶化的早期视神经乳头水肿速度：基于循证医学的综述 https://news.medxy.ai/ja/naion-optic-nerve-swelling/Medxy AIja2026-10-06T07:07:48-07:00NAIONの視機能悪化を左右する早期視神経乳頭腫脹速度：エビデンスに基づく総説 https://news.medxy.ai/vi/optic-nerve-conduction-speed/Medxy AIvi2026-10-06T07:07:22-07:00Tốc độ phù đầu dây thần kinh thị giác sớm liên quan với suy giảm thị lực trong bệnh lý thần kinh thị giác thiếu máu cục bộ trước không do động mạch: Tổng quan dựa trên bằng chứng https://news.medxy.ai/early-optic-nerve-head-swelling-rate-correlates-with-visual-decline-in-nonarteritic-anterior-ischemic-optic-neuropathy-an-evidence-based-review/Medxy AIen2026-10-06T07:06:59-07:00Early Optic Nerve Head Swelling Rate Correlates with Visual Decline in Nonarteritic Anterior Ischemic Optic Neuropathy: An Evidence-Based Review https://news.medxy.ai/zh/cetp-inhibition-benefits-risks/Medxy AIzh2026-10-06T07:06:13-07:00CETP抑制：心血管获益与年龄相关性黄斑变性风险之间的“双刃剑” https://news.medxy.ai/ja/cetp-inhibition-risk/Medxy AIja2026-10-06T07:05:50-07:00CETP阻害は心血管保護か、網膜リスクか：加齢黄斑変性をめぐる遺伝学的検証 https://news.medxy.ai/vi/cetp-inhibition-tradeoff/Medxy AIvi2026-10-06T07:05:29-07:00Ức chế CETP: “con dao hai lưỡi” giữa lợi ích tim mạch và nguy cơ thoái hóa hoàng điểm do tuổi tác https://news.medxy.ai/cholesteryl-ester-transfer-protein-inhibition-a-double-edged-sword-in-cardiovascular-health-and-age-related-macular-degeneration-risk/Medxy AIen2026-10-06T07:05:08-07:00Cholesteryl Ester Transfer Protein Inhibition: A Double-Edged Sword in Cardiovascular Health and Age-Related Macular Degeneration Risk https://news.medxy.ai/zh/remote-eye-pressure-monitoring-2/Medxy AIzh2026-10-06T07:04:31-07:00远程监测眼压与新型阈值指标，可预测治疗中开角型青光眼的视野进展 https://news.medxy.ai/vi/remote-intraocular-pressure/Medxy AIvi2026-10-06T07:03:50-07:00Theo dõi áp lực nội nhãn từ xa và các chỉ số ngưỡng mới dự đoán tiến triển thị trường ở glaucoma góc mở đã điều trị https://news.medxy.ai/remote-intraocular-pressure-monitoring-and-novel-threshold-metrics-predict-visual-field-progression-in-treated-open-angle-glaucoma/Medxy AIen2026-10-06T07:03:28-07:00Remote Intraocular Pressure Monitoring and Novel Threshold Metrics Predict Visual Field Progression in Treated Open-Angle Glaucoma https://news.medxy.ai/zh/81121-2/Medxy AIzh2026-10-06T07:02:51-07:00头颈部癌放疗后的长期阿片类药物使用：患病率、风险因素及临床意义 https://news.medxy.ai/ja/opioid-use-head-neck-cancer/Medxy AIja2026-10-06T07:02:30-07:00頭頸部癌の放射線治療後に長引くオピオイド使用：有病率・リスク因子・臨床的意義 https://news.medxy.ai/vi/long-term-opioid-use/Medxy AIvi2026-10-06T07:02:07-07:00Sử dụng opioid kéo dài sau xạ trị ở ung thư đầu và cổ: Tỷ lệ hiện mắc, yếu tố nguy cơ và ý nghĩa lâm sàng https://news.medxy.ai/long-term-opioid-use-after-radiation-therapy-in-head-and-neck-cancer-prevalence-risk-factors-and-clinical-implications/Medxy AIen2026-10-06T07:01:46-07:00Long-Term Opioid Use After Radiation Therapy in Head and Neck Cancer: Prevalence, Risk Factors, and Clinical Implications https://news.medxy.ai/zh/testosterone-suppression-cancer-risk/Medxy AIzh2026-10-06T07:01:12-07:00抑制睾酮或可降低男性喉癌与下咽癌风险：来自瑞典大型队列的研究发现 https://news.medxy.ai/ja/81111-2/Medxy AIja2026-10-06T07:00:54-07:00テストステロンの抑制が男性の喉頭がん・下咽頭がんのリスクを低減させる可能性 https://news.medxy.ai/vi/testosterone-inhibition-cancer-risk/Medxy AIvi2026-10-06T07:00:34-07:00Ức chế testosterone có liên quan đến giảm nguy cơ ung thư biểu mô tế bào vảy thanh quản và hạ họng ở nam giới: Góc nhìn từ một đoàn hệ lớn tại Thụy Điển https://news.medxy.ai/testosterone-inhibition-and-reduced-risk-of-laryngeal-and-hypopharyngeal-squamous-cell-carcinoma-in-men-insights-from-a-large-swedish-cohort/Medxy AIen2026-10-06T07:00:14-07:00Testosterone Inhibition and Reduced Risk of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma in Men: Insights from a Large Swedish Cohort https://news.medxy.ai/zh/salivary-gland-tumor-diagnosis/Medxy AIzh2026-10-06T06:59:38-07:00大唾液腺肿瘤诊断的新进展：粗针穿刺活检的临床价值 https://news.medxy.ai/ja/81099-2/Medxy AIja2026-10-06T06:59:19-07:00大唾液腺腫瘍診断の新たな進展：太い針による穿刺生検の臨床的意義 https://news.medxy.ai/vi/salivary-gland-biopsy/Medxy AIvi2026-10-06T06:59:00-07:00Nâng cao chẩn đoán u tuyến nước bọt lớn: Giá trị lâm sàng của sinh thiết kim lõi https://news.medxy.ai/advancing-diagnosis-of-major-salivary-gland-tumors-the-clinical-value-of-core-needle-biopsy/Medxy AIen2026-10-06T06:58:39-07:00Advancing Diagnosis of Major Salivary Gland Tumors: The Clinical Value of Core Needle Biopsy https://news.medxy.ai/zh/bone-healing-factors/Medxy AIzh2026-10-06T06:58:06-07:00骨愈合是否关键？骨性微血管中面部重建结局的影响因素分析 https://news.medxy.ai/ja/bone-healing-impact/Medxy AIja2026-10-06T06:57:45-07:00骨癒合は転帰に影響するのか：骨性マイクロバスキュラー中顔面再建における検討 https://news.medxy.ai/vi/bone-healing-impact-2/Medxy AIvi2026-10-06T06:57:23-07:00Đánh giá ảnh hưởng của sự liền xương đối với kết quả tái tạo tầng giữa mặt bằng vạt vi phẫu xương https://news.medxy.ai/evaluating-the-impact-of-bony-union-on-outcomes-in-osseous-microvascular-midface-reconstruction/Medxy AIen2026-10-06T06:57:01-07:00Evaluating the Impact of Bony Union on Outcomes in Osseous Microvascular Midface Reconstruction https://news.medxy.ai/zh/fungal-sinusitis-differentiation/Medxy AIzh2026-10-06T06:56:25-07:00从结构化组织病理学看沙特队列中变应性真菌性鼻-鼻窦炎与嗜酸性粒细胞性伴鼻息肉慢性鼻-鼻窦炎的鉴别 https://news.medxy.ai/ja/eosinophilic-sinusitis/Medxy AIja2026-10-06T06:56:04-07:00アレルギー性真菌性鼻副鼻腔炎と鼻茸を伴う好酸球性慢性鼻副鼻腔炎の鑑別：サウジアラビア・コホートにおける構造化病理組織学からの知見 https://news.medxy.ai/vi/allergic-fungal-vs-eosinophilic-sinusitis/Medxy AIvi2026-10-06T06:55:43-07:00Phân biệt viêm mũi xoang do nấm dị ứng với viêm mũi xoang mạn tính tăng bạch cầu ái toan có polyp mũi: góc nhìn từ mô bệnh học có cấu trúc trên một đoàn hệ Saudi Arabia https://news.medxy.ai/differentiating-allergic-fungal-rhinosinusitis-from-eosinophilic-chronic-rhinosinusitis-with-nasal-polyps-insights-from-structured-histopathology-in-a-saudi-cohort/Medxy AIen2026-10-06T06:55:22-07:00Differentiating Allergic Fungal Rhinosinusitis from Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: Insights from Structured Histopathology in a Saudi Cohort https://news.medxy.ai/ja/appendiceal-abscess-management/Medxy AIja2026-10-06T06:54:46-07:00虫垂膿瘍をどう扱うか――2025年イタリア・コンセンサスが示す実践的フレームワーク https://news.medxy.ai/vi/appendix-abscess-management/Medxy AIvi2026-10-06T06:54:11-07:00Áp-xe ruột thừa: Khung xử trí thực hành dựa trên sinh lý học từ Đồng thuận Ý 2025 https://news.medxy.ai/zh/81074-2/Medxy AIzh2026-10-06T06:53:38-07:00如何处理阑尾脓肿——2025年意大利共识提出的实践框架 https://news.medxy.ai/a-practical-physiology-driven-framework-for-appendiceal-abscess-key-recommendations-from-the-2025-italian-consensus/Medxy AIen2026-10-06T06:53:08-07:00A Practical, Physiology-Driven Framework for Appendiceal Abscess: Key Recommendations from the 2025 Italian Consensus https://news.medxy.ai/zh/frailty-predicts-outcomes/Medxy AIzh2026-10-06T06:52:05-07:00超越年龄：虚弱比实际年龄更能预测老年患者术后结局 https://news.medxy.ai/ja/beyond-age-frailty/Medxy AIja2026-10-06T06:51:47-07:00年齢を超えて：高齢者の術後転帰を最もよく予測するのはフレイル https://news.medxy.ai/vi/age-frailty-surgery/Medxy AIvi2026-10-06T06:51:24-07:00Vượt qua tuổi tác: Suy yếu là yếu tố dự đoán vượt trội về kết cục sau phẫu thuật ở người cao tuổi https://news.medxy.ai/beyond-age-frailty-as-a-superior-predictor-of-postoperative-outcomes-in-older-adults/Medxy AIen2026-10-06T06:51:03-07:00Beyond Age: Frailty as a Superior Predictor of Postoperative Outcomes in Older Adults https://news.medxy.ai/zh/aldo-renin-ratio-threshold/Medxy AIzh2026-10-06T06:50:27-07:00优化醛固酮/肾素比值阈值：提高正常醛固酮水平患者原发性醛固酮增多症的检出率 https://news.medxy.ai/ja/aldosterone-renin-ratio-2/Medxy AIja2026-10-06T06:50:04-07:00原発性アルドステロン症の拾い上げを高める：アルドステロン／レニン比の閾値再検討 https://news.medxy.ai/vi/aldosterone-renin-ratio-3/Medxy AIvi2026-10-06T06:49:39-07:00Hiệu chỉnh ngưỡng tỷ lệ aldosterone trên renin: Nâng cao phát hiện cường aldosterone tiên phát ở bệnh nhân có nồng độ aldosterone bình thường https://news.medxy.ai/refining-aldosterone-to-renin-ratio-thresholds-improving-detection-of-primary-aldosteronism-in-patients-with-normal-aldosterone-levels/Medxy AIen2026-10-06T06:49:14-07:00Refining Aldosterone-to-Renin Ratio Thresholds: Improving Detection of Primary Aldosteronism in Patients with Normal Aldosterone Levels https://news.medxy.ai/zh/racial-disparities-trauma-care/Medxy AIzh2026-10-06T06:48:35-07:00创伤患者院前救治中的种族差异：基于证据的综述 https://news.medxy.ai/ja/racial-disparities-prehospital-care/Medxy AIja2026-10-06T06:48:13-07:00受傷患者の病院前介入における人種差：エビデンスに基づく総説 https://news.medxy.ai/vi/81049-2/Medxy AIvi2026-10-06T06:47:49-07:00Chênh lệch về chủng tộc trong chăm sóc tiền bệnh viện cho bệnh nhân chấn thương: Tổng quan dựa trên bằng chứng https://news.medxy.ai/racial-disparities-in-prehospital-interventions-among-injured-patients-an-evidence-based-review/Medxy AIen2026-10-06T06:47:27-07:00Racial Disparities in Prehospital Interventions Among Injured Patients: An Evidence-Based Review https://news.medxy.ai/zh/81039-2/Medxy AIzh2026-10-06T06:46:32-07:00良性及低级别胰头肿瘤：肿瘤剜除术与胰十二指肠切除术的当代证据综合分析 https://news.medxy.ai/ja/benign-pancreatic-tumor-surgery/Medxy AIja2026-10-06T06:46:05-07:00良性・低悪性度膵頭部腫瘍に対する核出術と膵頭十二指腸切除術：最新エビデンスの総括 https://news.medxy.ai/vi/tumor-removal-options/Medxy AIvi2026-10-06T06:45:41-07:00Bóc nhân khối u hay cắt tá tràng – tụy: lựa chọn nào tối ưu cho khối u lành tính và độ thấp ở đầu tụy? https://news.medxy.ai/enucleation-vs-pancreatoduodenectomy-for-benign-and-low-grade-pancreatic-head-tumors-a-contemporary-evidence-synthesis/Medxy AIen2026-10-06T06:45:15-07:00Enucleation vs Pancreatoduodenectomy for Benign and Low-Grade Pancreatic Head Tumors: A Contemporary Evidence Synthesis https://news.medxy.ai/zh/robot-assisted-vs-thoracoscopic/Medxy AIzh2026-10-06T06:44:26-07:00机器人辅助还是胸腹腔镜？食管癌手术精准度的进一步提升 https://news.medxy.ai/ja/robotic-surgery-advances/Medxy AIja2026-10-06T06:44:06-07:00ロボット手術は胸腹腔鏡手術を上回るか？　食道癌治療における精密外科の新展開 https://news.medxy.ai/vi/robotic-esophagectomy/Medxy AIvi2026-10-06T06:43:41-07:00Phẫu thuật cắt thực quản bằng robot hay thoracolaparoscopic: Nâng cao độ chính xác trong điều trị ung thư thực quản https://news.medxy.ai/robotic-vs-thoracolaparoscopic-esophagectomy-advancing-surgical-precision-in-esophageal-cancer-treatment/Medxy AIen2026-10-06T06:43:19-07:00Robotic vs Thoracolaparoscopic Esophagectomy: Advancing Surgical Precision in Esophageal Cancer Treatment https://news.medxy.ai/zh/medicaid-expansion-survival/Medxy AIzh2026-10-06T06:42:39-07:00Medicaid扩展对结直肠癌肝转移患者生存的影响：基于人群的分析 https://news.medxy.ai/ja/81014-2/Medxy AIja2026-10-06T06:42:21-07:00メディケイドの拡大が結腸直腸癌の肝転移患者の生存に及ぼす影響 https://news.medxy.ai/vi/81013-2/Medxy AIvi2026-10-06T06:41:58-07:00Tác động của việc mở rộng Medicaid đến tỷ lệ sống còn ở bệnh nhân ung thư đại trực tràng di căn gan https://news.medxy.ai/impact-of-medicaid-expansion-on-survival-in-colorectal-cancer-with-liver-metastasis-a-population-based-analysis/Medxy AIen2026-10-06T06:41:35-07:00Impact of Medicaid Expansion on Survival in Colorectal Cancer with Liver Metastasis: A Population-Based Analysis https://news.medxy.ai/zh/81006-2/Medxy AIzh2026-10-06T06:40:58-07:00针对肝细胞癌的肝移植：完全病理学缓解对预后的影响及治疗方案的差异——基于美国全国数据库的研究 https://news.medxy.ai/ja/liver-transplant-outcomes/Medxy AIja2026-10-06T06:40:34-07:00肝細胞癌に対する肝移植：完全病理学的奏効の予後への影響と治療法の差異―米国全国データベース研究 https://news.medxy.ai/vi/81000-2/Medxy AIvi2026-10-06T06:40:07-07:00Ghép gan điều trị ung thư biểu mô tế bào gan: Ảnh hưởng của đáp ứng bệnh học hoàn toàn đến tiên lượng và sự khác biệt về phương pháp điều trị – Nghiên cứu dựa trên cơ sở dữ liệu toàn quốc của Hoa Kỳ https://news.medxy.ai/liver-transplantation-hcc/Medxy AIen2026-10-06T06:39:42-07:00Liver Transplantation for Hepatocellular Carcinoma: Prognostic Impact of Complete Pathologic Response and Influence of Treatment Modality—A US National Database Study https://news.medxy.ai/zh/robot-assisted-esophagectomy/Medxy AIzh2026-10-06T06:38:48-07:00机器人辅助食管切除术：重塑食管癌外科治疗的新标杆 https://news.medxy.ai/ja/robotic-esophagectomy-guide/Medxy AIja2026-10-06T06:38:31-07:00食道癌手術の新たな指標を築くロボット支援食道切除術 https://news.medxy.ai/vi/robot-assisted-esophagectomy-2/Medxy AIvi2026-10-06T06:38:11-07:00Cắt thực quản hỗ trợ robot: Nâng tầm chuẩn mực phẫu thuật trong chăm sóc ung thư thực quản https://news.medxy.ai/robotic-assisted-esophagectomy-transforming-surgical-benchmarks-in-esophageal-cancer-care/Medxy AIen2026-10-06T06:37:53-07:00Robotic-Assisted Esophagectomy: Transforming Surgical Benchmarks in Esophageal Cancer Care https://news.medxy.ai/zh/80981-2/Medxy AIzh2026-10-06T06:37:21-07:00评估帕博利珠单抗、贝伐珠单抗联合口服节律性环磷酰胺治疗经多线治疗的铂耐药卵巢癌：真实世界疗效与临床启示 https://news.medxy.ai/ja/platinum-resistant-ovarian-cancer-treatment/Medxy AIja2026-10-06T06:36:58-07:00多治療歴プラチナ抵抗性卵巣癌に対するペムブロリズマブ・ベバシズマブ・経口メトロノミック・シクロホスファミドの評価：実臨床成績と臨床的示唆 https://news.medxy.ai/vi/80975-2/Medxy AIvi2026-10-06T06:36:33-07:00Phối hợp pembrolizumab, bevacizumab và cyclophosphamide đường uống theo phác đồ metronomic cho ung thư buồng trứng kháng platin đã trải qua nhiều đợt điều trị trước đó https://news.medxy.ai/evaluating-pembrolizumab-bevacizumab-and-oral-metronomic-cyclophosphamide-in-heavily-pretreated-platinum-resistant-ovarian-cancer-real-world-outcomes-and-clinical-implications/Medxy AIen2026-10-06T06:36:07-07:00Evaluating Pembrolizumab, Bevacizumab, and Oral Metronomic Cyclophosphamide in Heavily Pretreated Platinum-Resistant Ovarian Cancer: Real-World Outcomes and Clinical Implications https://news.medxy.ai/zh/endometrial-cancer-genetics/Medxy AIzh2026-10-06T06:35:23-07:00子宫内膜癌的遗传学检测：致病性胚系变异的流行率及其对临床实践的启示 https://news.medxy.ai/ja/80962-2/Medxy AIja2026-10-06T06:35:02-07:00子宮内膜癌の遺伝学的検査：病原性生殖細胞系列変異の有病率と臨床診療への示唆 https://news.medxy.ai/vi/80961-2/Medxy AIvi2026-10-06T06:34:42-07:00Xét nghiệm di truyền ung thư nội mạc tử cung: Tỷ lệ biến thể dòng mầm gây bệnh và ý nghĩa đối với thực hành lâm sàng https://news.medxy.ai/genetic-testing-in-endometrial-cancer-prevalence-of-pathogenic-germline-variants-and-implications-for-clinical-practice-in-a-diverse-community-cohort/Medxy AIen2026-10-06T06:34:18-07:00Genetic Testing in Endometrial Cancer: Prevalence of Pathogenic Germline Variants and Implications for Clinical Practice in a Diverse Community Cohort https://news.medxy.ai/zh/elagolix-pain-relief/Medxy AIzh2026-10-06T06:33:44-07:00III期多中心试验证实：elagolix缓解中重度子宫内膜异位症疼痛不劣于dienogest https://news.medxy.ai/ja/elagolix-vs-dienogest/Medxy AIja2026-10-06T06:33:20-07:00中等度〜重度子宮内膜症疼痛に対するElagolixとDienogestの有効性・安全性比較：第III相多施設試験からの知見 https://news.medxy.ai/vi/elagolix-dienogest-comparison/Medxy AIvi2026-10-06T06:32:56-07:00Elagolix hay dienogest: so sánh hiệu quả và độ an toàn trong giảm đau lạc nội mạc tử cung mức độ trung bình đến nặng từ thử nghiệm đa trung tâm giai đoạn III https://news.medxy.ai/comparative-efficacy-and-safety-of-elagolix-versus-dienogest-in-moderate-to-severe-endometriosis-pain-insights-from-a-phase-iii-multicentric-trial/Medxy AIen2026-10-06T06:32:33-07:00Comparative Efficacy and Safety of Elagolix Versus Dienogest in Moderate-to-Severe Endometriosis Pain: Insights from a Phase III Multicentric Trial https://news.medxy.ai/zh/perineal-injury-effects/Medxy AIzh2026-10-06T06:31:54-07:00二度会阴裂伤与会阴切开术后伤口并发症对盆底症状的长期影响：REPAIR研究带来的启示 https://news.medxy.ai/ja/pelvic-floor-symptoms/Medxy AIja2026-10-06T06:31:33-07:00第二度会陰裂傷・会陰切開後の骨盤底症状に対する創傷合併症の長期的影響：REPAIR研究からの知見 https://news.medxy.ai/vi/long-term-wound-effects/Medxy AIvi2026-10-06T06:31:13-07:00Ảnh hưởng lâu dài của biến chứng vết thương đến triệu chứng sàn chậu sau rách tầng sinh môn độ 2 và episiotomy: phát hiện từ nghiên cứu REPAIR https://news.medxy.ai/long-term-impact-of-wound-complications-on-pelvic-floor-symptoms-following-second-degree-tears-and-episiotomy-insights-from-the-repair-study/Medxy AIen2026-10-06T06:30:52-07:00Long-Term Impact of Wound Complications on Pelvic Floor Symptoms Following Second-Degree Tears and Episiotomy: Insights from the REPAIR Study https://news.medxy.ai/zh/obgyn-ai-competency/Medxy AIzh2026-10-06T06:30:14-07:00妇产科临床AI胜任力：在创新与患者安全、责任之间寻求平衡 https://news.medxy.ai/ja/obgyn-ai-competence/Medxy AIja2026-10-06T06:29:58-07:00産科・婦人科における臨床AIコンピテンス：革新と患者安全・説明責任の両立 https://news.medxy.ai/vi/ai-clinical-capacity/Medxy AIvi2026-10-06T06:29:38-07:00Năng lực lâm sàng về AI trong sản khoa và phụ khoa: Cân bằng giữa đổi mới, an toàn người bệnh và trách nhiệm giải trình https://news.medxy.ai/clinical-ai-competence-in-obstetrics-and-gynecology-balancing-innovation-with-patient-safety-and-accountability/Medxy AIen2026-10-06T06:29:19-07:00Clinical AI Competence in Obstetrics and Gynecology: Balancing Innovation with Patient Safety and Accountability https://news.medxy.ai/zh/early-adult-granulosa-tumor/Medxy AIzh2026-10-06T06:28:43-07:00早期成人颗粒细胞瘤的保留卵巢手术：生存结局不劣于双侧卵巢切除术 https://news.medxy.ai/ja/early-adult-granulosa-cell-tumor/Medxy AIja2026-10-06T06:28:21-07:00早期成人型顆粒膜細胞腫に対する卵巣温存手術：両側卵巣摘出術に匹敵する生存成績 https://news.medxy.ai/vi/ovarian-conservation-surgery/Medxy AIvi2026-10-06T06:28:00-07:00Phẫu thuật bảo tồn buồng trứng ở u tế bào hạt trưởng thành giai đoạn sớm: Kết cục sống còn tương đương cắt buồng trứng hai bên https://news.medxy.ai/ovarian-sparing-surgery-in-early-stage-adult-granulosa-cell-tumors-comparable-survival-outcomes-to-bilateral-oophorectomy/Medxy AIen2026-10-06T06:27:39-07:00Ovarian-Sparing Surgery in Early-Stage Adult Granulosa Cell Tumors: Comparable Survival Outcomes to Bilateral Oophorectomy https://news.medxy.ai/zh/carrier-screening-insights/Medxy AIzh2026-10-06T06:26:59-07:00优化携带者筛查：来自母胎医学实践的洞见与建议 https://news.medxy.ai/ja/80913-2/Medxy AIja2026-10-06T06:26:39-07:00保因者スクリーニングの最適化：母体胎児医学の実践から得られる知見と提言 https://news.medxy.ai/vi/80911-2/Medxy AIvi2026-10-06T06:26:19-07:00Tối ưu hóa Sàng lọc Người mang gen bệnh: Những hiểu biết và khuyến nghị từ thực tiễn Y học Bà mẹ – Thai nhi https://news.medxy.ai/optimizing-carrier-screening-insights-and-recommendations-from-a-maternal-fetal-medicine-practice/Medxy AIen2026-10-06T06:25:58-07:00Optimizing Carrier Screening: Insights and Recommendations From a Maternal-Fetal Medicine Practice https://news.medxy.ai/zh/lichen-sclerosus-treatment/Medxy AIzh2026-10-06T06:25:20-07:00外阴硬化性苔藓治疗新进展：CO2 激光与外用丙酸氯倍他索的疗效比较 https://news.medxy.ai/ja/vulvar-lichen-sclerosus-treatment/Medxy AIja2026-10-06T06:24:59-07:00外陰部硬化性苔癬に対するCO2レーザーと外用クロベタゾールの比較：症状管理を変える新知見 https://news.medxy.ai/vi/co2-laser-vs-clobetasol/Medxy AIvi2026-10-06T06:24:40-07:00So sánh liệu pháp laser CO2 với clobetasol bôi trong lichen sclerosus âm hộ: Bước tiến mới trong kiểm soát triệu chứng https://news.medxy.ai/comparing-co2-laser-therapy-and-topical-clobetasol-in-vulvar-lichen-sclerosus-breakthroughs-in-symptom-management/Medxy AIen2026-10-06T06:24:19-07:00Comparing CO2 Laser Therapy and Topical Clobetasol in Vulvar Lichen Sclerosus: Breakthroughs in Symptom Management https://news.medxy.ai/patient-specific-pessaries-after-suboptimal-outcomes-with-standard-pessary-use-a-multicenter-retrospective-case-series/Medxy AIen2026-10-06T06:23:45-07:00Patient-Specific Pessaries After Suboptimal Outcomes With Standard Pessary Use: A Multicenter Retrospective Case Series https://news.medxy.ai/zh/tesera-liver-cancer/Medxy AIzh2026-10-06T06:23:10-07:00TESERA：基于 H&E 全视野切片推动肝细胞癌形态学分型与预后分层 https://news.medxy.ai/ja/heslides-hepatocellular-carcinoma-subtypes/Medxy AIja2026-10-06T06:22:49-07:00H&E全スライド画像から肝細胞癌の形態学的サブタイプと予後を読み解くTESERA https://news.medxy.ai/tesera-advancing-morphologic-subtyping-and-prognostic-stratification-in-hepatocellular-carcinoma-using-he-whole-slide-images/Medxy AIen2026-10-06T06:22:01-07:00TESERA: Advancing Morphologic Subtyping and Prognostic Stratification in Hepatocellular Carcinoma Using H&E Whole-Slide Images https://news.medxy.ai/exceptional-and-durable-response-to-selpercatinib-in-a-patient-with-apparently-ret-negative-hras-and-nf1-mutated-metastatic-medullary-thyroid-carcinoma/Medxy AIen2026-10-06T06:03:01-07:00Exceptional and Durable Response to Selpercatinib in a Patient with Apparently RET-Negative, HRAS-, and NF1-Mutated Metastatic Medullary Thyroid Carcinoma